In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.
A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...
A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...
Our experiences leave traces in the brain, stored in small groups of cells called engrams. Engrams are thought to hold the ...
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback